Standard Cosentyx Starting Dosage
Cosentyx (secukinumab) for plaque psoriasis starts at 300 mg subcutaneously once weekly for the first 5 weeks (doses at Weeks 0, 1, 2, 3, 4). Maintenance follows at 300 mg every 4 weeks.[1]
Dosage Ramp-Up for Psoriatic Arthritis
Same initial 300 mg weekly for 5 weeks, then 300 mg every 4 weeks. For patients under 110 kg with inadequate response, stay at 300 mg; those over 110 kg may increase to 300 mg every 2 weeks after Week 4.[1]
Timeline for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Loading: 150 mg (or 300 mg for faster response) at Weeks 0, 1, 2, 3, 4. Maintenance: 150 mg (or 300 mg) every 4 weeks starting Week 8.[1]
Adjustments for Hidradenitis Suppurativa
300 mg weekly for 4 weeks (Weeks 0-3), then every 4 weeks. Increase to 300 mg every 2 weeks if no improvement by Week 16.[1]
Pediatric Dosage Timelines (Ages 6+ for Psoriasis/Enthesitis-Related Arthritis)
Weight-based: Under 50 kg starts at 75 mg weekly for 5 weeks, then every 4 weeks; 50 kg+ uses adult 300 mg schedule.[1]
When to Increase Dosage
Increases occur only for inadequate response, typically assessed at Week 12-16 depending on condition. No automatic escalations; consult prescriber for weight-based or efficacy-driven changes. Max dose is 300 mg.[1]
[1] Cosentyx Prescribing Information, Novartis, https://www.cosentyx.com/